We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK Launches Fixed-Dose Diabetes Drug Avandaryl
GSK Launches Fixed-Dose Diabetes Drug Avandaryl
May 10, 2006
GlaxoSmithKline (GSK) in February launched Avandaryl, a new fixed-dose combination product for Type 2 diabetes.